MEDINDIA
English
हिन्दी
Español
français
中文
Email
3-N-Butylphthalide
Butylphthalide may increase the anticoagulant activities of Eptifibatide.
Abciximab
Eptifibatide may increase the anticoagulant activities of Abciximab.
Acenocoumarol
Eptifibatide may increase the anticoagulant activities of Acenocoumarol.
Acetyl salicylate
The risk or severity of adverse effects can be increased when Eptifibatide is combined with Acetylsalicylic acid.
Aloxiprin
The risk or severity of adverse effects can be increased when Eptifibatide is combined with Aloxiprin.
alpha Tocopherol
Vitamin E may increase the antiplatelet activities of Eptifibatide.
Alprostadil
Alprostadil may increase the anticoagulant activities of Eptifibatide.
Alteplase
Eptifibatide may increase the anticoagulant activities of Alteplase.
Aminosalicylic Acid
The risk or severity of adverse effects can be increased when Eptifibatide is combined with Aminosalicylic Acid.
Anagrelide
Eptifibatide may increase the anticoagulant activities of Anagrelide.
Ancrod
Eptifibatide may increase the anticoagulant activities of Ancrod.
Anistreplase
Eptifibatide may increase the anticoagulant activities of Anistreplase.
Antithrombin III
Eptifibatide may increase the anticoagulant activities of Antithrombin III human.
Antithrombin III, Human
Eptifibatide may increase the anticoagulant activities of Antithrombin III human.
Apixaban
The risk or severity of adverse effects can be increased when Eptifibatide is combined with Apixaban.
Aprotinin
The therapeutic efficacy of Eptifibatide can be decreased when used in combination with Aprotinin.
Ardeparin
Eptifibatide may increase the anticoagulant activities of Ardeparin.
Argatroban
Eptifibatide may increase the anticoagulant activities of Argatroban.
Argatroban Anhydrous
Eptifibatide may increase the anticoagulant activities of Argatroban.
Aspirin
The risk or severity of adverse effects can be increased when Eptifibatide is combined with Acetylsalicylic acid.
Astaxanthin
Eptifibatide may increase the anticoagulant activities of Astaxanthin.
Azelastine
Azelastine may increase the anticoagulant activities of Eptifibatide.
Balsalazide
The risk or severity of adverse effects can be increased when Eptifibatide is combined with Balsalazide.
Becaplermin
Eptifibatide may increase the anticoagulant activities of Becaplermin.
Bemiparin
Eptifibatide may increase the anticoagulant activities of Bemiparin.
Bivalirudin
Eptifibatide may increase the anticoagulant activities of Bivalirudin.
Cangrelor
Eptifibatide may increase the anticoagulant activities of Cangrelor.
Certoparin
Eptifibatide may increase the anticoagulant activities of Certoparin.
Cilostazol
Eptifibatide may increase the anticoagulant activities of Cilostazol.
Citric Acid
Eptifibatide may increase the anticoagulant activities of Citric Acid.
Citric Acid, Anhydrous
Eptifibatide may increase the anticoagulant activities of Citric Acid.
Clopidogrel
Eptifibatide may increase the anticoagulant activities of Clopidogrel.
COLLAGENASE
The risk or severity of adverse effects can be increased when Eptifibatide is combined with Collagenase clostridium histolyticum.
collagenase Clostridium histolyticum
The risk or severity of adverse effects can be increased when Eptifibatide is combined with Collagenase clostridium histolyticum.
Dabigatran Etexilate
Eptifibatide may increase the anticoagulant activities of Dabigatran etexilate.
Dalteparin
Eptifibatide may increase the anticoagulant activities of Dalteparin.
Danaparoid
Eptifibatide may increase the anticoagulant activities of Danaparoid.
Dasatinib
Dasatinib may increase the anticoagulant activities of Eptifibatide.
Dasatinib Anhydrous
Dasatinib may increase the anticoagulant activities of Eptifibatide.
Defibrotide
Eptifibatide may increase the anticoagulant activities of Defibrotide.
Deoxycholate
The risk or severity of adverse effects can be increased when Eptifibatide is combined with Deoxycholic Acid.
Deoxycholic Acid
The risk or severity of adverse effects can be increased when Eptifibatide is combined with Deoxycholic Acid.
Desirudin
Eptifibatide may increase the anticoagulant activities of Desirudin.
Dextran
Eptifibatide may increase the anticoagulant activities of Dextran.
Dextran 40
Eptifibatide may increase the anticoagulant activities of Dextran 40.
Dextran 70
Eptifibatide may increase the anticoagulant activities of Dextran 70.
Dextran 75
Eptifibatide may increase the anticoagulant activities of Dextran 75.
Dicumarol
Eptifibatide may increase the anticoagulant activities of Dicoumarol.
Diflunisal
The risk or severity of adverse effects can be increased when Eptifibatide is combined with Diflunisal.
Dipyridamole
Eptifibatide may increase the anticoagulant activities of Dipyridamole.
Drotrecogin Alfa
Eptifibatide may increase the anticoagulant activities of Drotrecogin alfa.
Edetic Acid
Eptifibatide may increase the anticoagulant activities of Edetic Acid.
Edoxaban
Eptifibatide may increase the anticoagulant activities of Edoxaban.
Enoxaparin
Eptifibatide may increase the anticoagulant activities of Enoxaparin.
Enoxaparin sodium
Eptifibatide may increase the anticoagulant activities of Enoxaparin.
Epinastine
Epinastine may increase the anticoagulant activities of Eptifibatide.
Epoprostenol
Eptifibatide may increase the anticoagulant activities of Epoprostenol.
Ethylenediaminetetraacetate
Eptifibatide may increase the anticoagulant activities of Edetic Acid.
Ferulic Acid
Eptifibatide may increase the anticoagulant activities of Ferulic acid.
Fibrinolysis Inhibitor
The therapeutic efficacy of Eptifibatide can be decreased when used in combination with Aprotinin.
Fluindione
Eptifibatide may increase the anticoagulant activities of Fluindione.
Fondaparinux
Eptifibatide may increase the anticoagulant activities of Fondaparinux.
Fondaparinux sodium
Eptifibatide may increase the anticoagulant activities of Fondaparinux sodium.
Glucosamine
Glucosamine may increase the antiplatelet activities of Eptifibatide.
Heparin
Eptifibatide may increase the anticoagulant activities of Heparin.
Hydroxytyrosol
Hydroxytyrosol may increase the anticoagulant activities of Eptifibatide.
Ibritumomab Tiuxetan
The risk or severity of adverse effects can be increased when Eptifibatide is combined with Ibritumomab tiuxetan.
Ibrutinib
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Eptifibatide.
Icosapent Ethyl
Icosapent ethyl may increase the anticoagulant activities of Eptifibatide.
Ifenprodil
Ifenprodil may increase the anticoagulant activities of Eptifibatide.
Iloprost
Eptifibatide may increase the anticoagulant activities of Iloprost.
Indobufen
Eptifibatide may increase the anticoagulant activities of Indobufen.
Ketanserin
Ketanserin may increase the anticoagulant activities of Eptifibatide.
Lepirudin
Eptifibatide may increase the anticoagulant activities of Lepirudin.
Mesalamine
The risk or severity of adverse effects can be increased when Eptifibatide is combined with Mesalazine.
Methyl Salicylate
The risk or severity of adverse effects can be increased when Eptifibatide is combined with Methyl salicylate.
Milrinone
Milrinone may increase the anticoagulant activities of Eptifibatide.
Nadroparin
Eptifibatide may increase the anticoagulant activities of Nadroparin.
Nimesulide
Nimesulide may increase the anticoagulant activities of Eptifibatide.
Obinutuzumab
The risk or severity of adverse effects can be increased when Eptifibatide is combined with Obinutuzumab.
Olsalazine
The risk or severity of adverse effects can be increased when Eptifibatide is combined with Olsalazine.
Omega-3 Fatty Acids
Omega-3 fatty acids may increase the antiplatelet activities of Eptifibatide.
Parnaparin
Eptifibatide may increase the anticoagulant activities of Parnaparin.
Pentaerythritol Tetranitrate
Eptifibatide may increase the anticoagulant activities of Pentaerythritol Tetranitrate.
Pentosan Polysulfate
The risk or severity of adverse effects can be increased when Pentosan Polysulfate is combined with Eptifibatide.
Pentoxifylline
Pentoxifylline may increase the antiplatelet activities of Eptifibatide.
Phenindione
Eptifibatide may increase the anticoagulant activities of Phenindione.
Phenprocoumon
Eptifibatide may increase the anticoagulant activities of Phenprocoumon.
Phospholipids
Omega-3 fatty acids may increase the antiplatelet activities of Eptifibatide.
Plasmin
Eptifibatide may increase the anticoagulant activities of Fibrinolysin.
Prasugrel
Eptifibatide may increase the anticoagulant activities of Prasugrel.
protein C, human
Eptifibatide may increase the anticoagulant activities of Protein C.
protein S, human
Eptifibatide may increase the anticoagulant activities of Protein S human.
Protocatechualdehyde
Eptifibatide may increase the anticoagulant activities of Protocatechualdehyde.
Resveratrol
Resveratrol may increase the anticoagulant activities of Eptifibatide.
Reteplase
Eptifibatide may increase the anticoagulant activities of Reteplase.
Reviparin
Eptifibatide may increase the anticoagulant activities of Reviparin.
Reviparin sodium
Eptifibatide may increase the anticoagulant activities of Reviparin.
Rivaroxaban
Eptifibatide may increase the anticoagulant activities of Rivaroxaban.
Rosiglitazone
Eptifibatide may increase the anticoagulant activities of Rosiglitazone.
Salicylic Acid
The risk or severity of adverse effects can be increased when Eptifibatide is combined with Salicylic acid.
Selexipag
Eptifibatide may increase the anticoagulant activities of Selexipag.
Sevoflurane
Sevoflurane may increase the anticoagulant activities of Eptifibatide.
Streptokinase
Eptifibatide may increase the anticoagulant activities of Streptokinase.
Tenecteplase
Eptifibatide may increase the anticoagulant activities of Tenecteplase.
Ticagrelor
Eptifibatide may increase the anticoagulant activities of Ticagrelor.
Ticlopidine
Eptifibatide may increase the anticoagulant activities of Ticlopidine.
Tinzaparin
Eptifibatide may increase the anticoagulant activities of Tinzaparin.
Tinzaparin sodium
Eptifibatide may increase the anticoagulant activities of Tinzaparin.
Tipranavir
Tipranavir may increase the antiplatelet activities of Eptifibatide.
Tirofiban
Eptifibatide may increase the anticoagulant activities of Tirofiban.
Tositumomab
The risk or severity of adverse effects can be increased when Eptifibatide is combined with Tositumomab.
Tranilast
Tranilast may increase the anticoagulant activities of Eptifibatide.
Trapidil
Trapidil may increase the anticoagulant activities of Eptifibatide.
Treprostinil
Eptifibatide may increase the anticoagulant activities of Treprostinil.
Triflusal
Eptifibatide may increase the anticoagulant activities of Triflusal.
Trolamine Salicylate
The risk or severity of adverse effects can be increased when Eptifibatide is combined with Trolamine salicylate.
Troxerutin
Eptifibatide may increase the anticoagulant activities of Troxerutin.
Urokinase
Eptifibatide may increase the anticoagulant activities of Urokinase.
Vitamin E
Vitamin E may increase the antiplatelet activities of Eptifibatide.
Vorapaxar
Eptifibatide may increase the anticoagulant activities of Vorapaxar.
Warfarin
Eptifibatide may increase the anticoagulant activities of Warfarin.
